Search Results - "Laschinsky, Christina"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Clinical Use of PET/MR in Oncology: An Update by Seifert, Robert, Kersting, David, Rischpler, Christoph, Opitz, Marcel, Kirchner, Julian, Pabst, Kim M., Mavroeidi, Ilektra-Antonia, Laschinsky, Christina, Grueneisen, Johannes, Schaarschmidt, Benedikt, Catalano, Onofrio Antonio, Herrmann, Ken, Umutlu, Lale

    Published in Seminars in nuclear medicine (01-05-2022)
    “…The combination of PET and MRI is one of the recent advances of hybrid imaging. Yet to date, the adoption rate of PET/MRI systems has been rather slow. This…”
    Get full text
    Journal Article
  2. 2

    Onkologische Theranostik in der Nuklearmedizin by Laschinsky Christina, Herrmann Ken Prof Dr med, Fendler Wolfgang Prof Dr med, Nader Michael Dr rer nat, Lahner, Harald Dr, Hadaschik Boris Prof Dr med, Sandach Patrick

    Published in Radiologe (01-10-2022)
    “…ZusammenfassungDas Prinzip der Theranostik beschreibt die sowohl diagnostische als auch therapeutische Nutzung radioaktiver Nuklide, geknüpft an biochemisch…”
    Get full text
    Journal Article
  3. 3

    NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear Medicine by Laschinsky, Christina, Welsner, Matthias, Mahabadi, Amir A, Lahner, Harald, Hautzel, Hubertus

    Published in Clinical nuclear medicine (01-02-2024)
    “…Carcinoid heart disease (Hedinger syndrome) is a long-term consequence in hormone-active neuroendocrine tumors with hepatic metastases and carcinoid syndrome…”
    Get full text
    Journal Article
  4. 4

    Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma by Laschinsky, Christina, Theurer, Sarah, Herold, Thomas, Rawitzer, Josefine, Weber, Frank, Herrmann, Ken, Brandenburg, Tim, Führer-Sakel, Dagmar, Fendler, Wolfgang P, Weber, Manuel

    Published in Journal of Nuclear Medicine (01-12-2023)
    “…The onset of radioiodine-refractory thyroid carcinoma (RR-TC) is a negative predictor of survival and has been linked to the presence of BRAF mutations in…”
    Get full text
    Journal Article
  5. 5
  6. 6